Delivery Order SPE2DE24DA017-SPE2D625F0BEJ
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,430.88 on July 23, 2025, for the supply of ARTHREX ANGEL PRP Kit (US Tray). This fixed-price delivery order with economic price adjustment is scheduled for completion by July 28, 2025, and will be performed at Arthrex's Naples, FL facility. The award was issued through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $14,308.80 delivery order from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for the Arthrex Angel PRP Kit (US Tray). This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 30, 2025, and was awarded without a set-aside designation, reflecting Arthrex's competitive strength in the federal orthopedic medical...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, received a $8,943 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for the ARTHREX ANGEL PRP Kit (US Tray). The delivery order, which carries an ultimate completion date of July 30, 2025, was awarded without set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The work will be performed in Naples,...
- Arthrex Inc., a leading developer and manufacturer of minimally invasive orthopedic medical technologies based in Naples, Florida, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for the supply of ARTHREX ANGEL PRP Kits. The contract, valued at $3,577.20, is structured as a fixed-price delivery order with economic price adjustment provisions and has an ultimate completion date of July 30, 2025. This award was made without a set-aside...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, for the supply of ARTHREX ANGEL PRP Kits. This fixed-price delivery order, valued at $12,475.65 with economic price adjustment provisions, is scheduled for completion by August 6, 2025, and will be fulfilled at the company's Naples facility. The contract was awarded without any set-aside designation, reflecting...
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $3,235.68 on July 31, 2025, by the Defense Logistics Agency's Medical Supply Chain. The delivery order, designated as a fixed-price contract with economic price adjustment provisions, calls for delivery of an Angel System with Aspiration Kit and ACDA components to be completed by August 5, 2025. The contract was executed...
- Arthrex Inc., headquartered in Naples, Florida, received a $5,365.80 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for the ARTHREX ANGEL PRP Kit (US Tray). The contract represents a non-set-aside award with a completion date of July 30, 2025, and will be performed at the company's Naples, Florida facility. This delivery order falls under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $3,577.20 from the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, with an ultimate completion date of August 6, 2025. The delivery order covers the Arthrex ANGEL PRP Kit for the U.S. market, a specialized medical device used in orthopedic procedures. This award was not set aside for any specific business category, reflecting...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $7,154.40 for the ARTHREX ANGEL PRP Kit (US Tray) from the Defense Logistics Agency's Medical Supply Chain on August 3, 2025. The contract, which is not set aside for any specific business category, utilizes fixed-price pricing with economic price adjustment and carries an ultimate completion date of August 15, 2025. This delivery order is executed under...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $9,900.84 for the ARTHREX ANGEL PRP Kit (US Tray) by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 24, 2025. This fixed-price contract with economic price adjustment represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471.0 million and running...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F0BEJDelivery Order
Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $7,154.40 on August 4, 2025, for the Arthrex ANGEL PRP Kit (US Tray). This fixed-price delivery order with economic price adjustment is set to be completed by August 7, 2025, and will be performed at the company's Naples, Florida facility. The award was issued through the Defense Logistics Agency's Medical Supply Chain, a defense agency component responsible for managing medical supplies across the Department of Defense and affiliated healthcare systems. This delivery order is executed under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and running through September 1, 2029. The ANGEL PRP Kit is a specialized orthopedic medical product designed to support advanced surgical procedures, consistent with Arthrex's comprehensive portfolio of orthopedic implants, arthroscopic instruments, and biologics. The company maintains a strong competitive position in the federal orthopedic medical device market, with no set-aside designation applied to this award, reflecting its established capability to serve government healthcare requirements across the Department of Defense and Veterans Affairs systems nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 8/4/25 |